Warning: mkdir(): No space left on device in /www/wwwroot/zhenghe1718.com/func.php on line 127

Warning: file_put_contents(./cachefile_yuan/99dujia.com/cache/57/685de/c617c.html): failed to open stream: No such file or directory in /www/wwwroot/zhenghe1718.com/func.php on line 115
Anti-Smad4 (L43) Antibody |产品详情|进口榴莲视频免费观看采购网





    榴莲视频下载地址入口,8008APP幸福宝榴莲,榴莲视频免费观看,榴莲视频污污污下载

    订购信息
    上海榴莲视频下载地址入口生物科技公司
    Tel:400-968-7988    021-33779008
    Anti-Smad4 (L43) Antibody
    品牌:Antibodies
    货号:
    规格:50µl
    货期:

    Anti-Smad4 (L43) Antibody

    商品详情 参考文献 相关资料
    Name: Anti-Smad4 (L43) Antibody
    See all Smad4 primary antibodies
    Description: Rabbit polyclonal antibody to Smad4 (L43)
    Specificity: Smad4 (L43) pAb detects endogenous levels of Smad4 protein.
    Applications: WB, IHC, IF
    Reactivity: Human, Mouse, Rat
    Immunogen: Synthetic peptide, corresponding to amino acids12-64 of Human Smad4.
    Host: Rabbit
    Clonality: Polyclonal
    Conjugate: Unconjugated
    Molecular Weight: ~ 60 kDa
    Purity: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
    Product Form: 1 mg/ml in Phosphate buffered saline (PBS) with 0.05% sodium azide, approx. pH 7.2.
    Function: In muscle physiology, plays a central role in the balance between atrophy and hypertrophy. When recruited by MSTN, promotes atrophy response via phosphorylated SMAD2/4. MSTN decrease causes SMAD4 release and subsequent recruitment by the BMP pathway to promote hypertrophy via phosphorylated SMAD1/5/8. Acts synergistically with SMAD1 and YY1 in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression. Binds to SMAD binding elements (SBEs) (5'-GTCT/AGAC-3') within BMP response element (BMPRE) of cardiac activating regions (By similarity). Common SMAD (co-SMAD) is the coactivator and mediator of signal transduction by TGF-beta (transforming growth factor). Component of the heterotrimeric SMAD2/SMAD3-SMAD4 complex that forms in the nucleus and is required for the TGF-mediated signaling. Promotes binding of the SMAD2/SMAD4/FAST-1 complex to DNA and provides an activation function required for SMAD1 or SMAD2 to stimulate transcription. Component of the multimeric SMAD3/SMAD4/JUN/FOS complex which forms at the AP1 promoter site; required for synergistic transcriptional activity in response to TGF-beta. May act as a tumor suppressor. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator.
    Involvement in Disease: Pancreatic cancer: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue.

    Juvenile polyposis syndrome: Autosomal dominant gastrointestinal hamartomatous polyposis syndrome in which patients are at risk for developing gastrointestinal cancers. The lesions are typified by a smooth histological appearance, predominant stroma, cystic spaces and lack of a smooth muscle core. Multiple juvenile polyps usually occur in a number of Mendelian disorders. Sometimes, these polyps occur without associated features as in JPS; here, polyps tend to occur in the large bowel and are associated with an increased risk of colon and other gastrointestinal cancers.

    Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome: JP/HHT syndrome phenotype consists of the coexistence of juvenile polyposis (JIP) and hereditary hemorrhagic telangiectasia (HHT) [MIM:187300] in a single individual. JIP and HHT are autosomal dominant disorders with distinct and non-overlapping clinical features. The former, an inherited gastrointestinal malignancy predisposition, is caused by mutations in SMAD4 or BMPR1A, and the latter is a vascular malformation disorder caused by mutations in ENG or ACVRL1. All four genes encode proteins involved in the transforming-growth-factor-signaling pathway. Although there are reports of patients and families with phenotypes of both disorders combined, the genetic etiology of this association is unknown.

    Colorectal cancer: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history.

    Myhre syndrome: A syndrome characterized by pre- and postnatal growth deficiency, mental retardation, generalized muscle hypertrophy and striking muscular build, decreased joint mobility, cryptorchidism, and unusual facies. Dysmorphic facial features include microcephaly, midface hypoplasia, prognathism, and blepharophimosis. Typical skeletal anomalies are short stature, square body shape, broad ribs, iliac hypoplasia, brachydactyly, flattened vertebrae, and thickened calvaria. Other features, such as congenital heart disease, may also occur.
    Sequence Similarities: Belongs to the dwarfin/SMAD family.
    Post-Translational Modification: Phosphorylated by PDPK1.
    Cellular locations: Cytoplasm. Nucleus.

    Cytoplasmic in the absence of ligand. Migrates to the nucleus when complexed with R-SMAD (PubMed:15799969). PDPK1 prevents its nuclear translocations in response to TGF-beta (PubMed:17327236).
    Database Links:
  1. Entrez Gene: 4089?Human
  2. Entrez Gene: 17128?Mouse
  3. Entrez Gene: 50554?Rat
  4. Omim: 600993?Human
  5. SwissProt: Q13485?Human
  6. SwissProt: P97471?Mouse
  7. SwissProt: O70437?Rat
  8. Unigene: 75862?Human
  9. Unigene: 100399?Mouse
  10. Unigene: 9774?Rat
  11. Synonyms:
  12. (Small) Mothers Against Decapentaplegic Antibody
  13. Deleted in Pancreatic Carcinoma Antibody
  14. Deleted in Pancreatic Carcinoma 4 Antibody
  15. Deleted in pancreatic carcinoma locus 4 Antibody
  16. Deletion target in pancreatic carcinoma 4 Antibody
  17. DPC 4 Antibody
  18. DPC4 Antibody
  19. hSMAD4 Antibody
  20. JIP Antibody
  21. MAD homolog 4 Antibody
  22. MAD mothers against decapentaplegic Drosophila homolog 4 Antibody
  23. MAD mothers against decapentaplegic homolog 4 Antibody
  24. MADH 4 Antibody
  25. MADH4 Antibody
  26. Med Antibody
  27. Medea Antibody
  28. Mothers against decapentaplegic homolog 4 Antibody
  29. Mothers against decapentaplegic, Drosophila, homolog of, 4 Antibody
  30. Mothers against DPP homolog 4 Antibody
  31. MYHRS Antibody
  32. OTTHUMP00000163548 Antibody
  33. SMA- and MAD-related protein 4 Antibody
  34. SMAD 4 Antibody
  35. SMAD family member 4 Antibody
  36. SMAD mothers against DPP homolog 4 Antibody
  37. Smad4 Antibody
  38. SMAD4_HUMAN Antibody
  39. Information: Target information shown above is from the UniProt Consortium.
    • 关于榴莲视频下载地址入口
    • 购物流程
    • 支付方式
    • 配送方式
    Copyright@ 2003-2026  进口榴莲视频免费观看采购网版权所有     

    BIOLEAF热搜   BIOLEAF8008APP幸福宝榴莲   BIOLEAF ELISA   BIOLEAF榴莲视频免费观看   BIOLEAF品牌   BIOLEAF抗体   BIOLEAF耗材   BIOLEAF小仪器

    sitemap   细胞库查询   危险品图标

    本公司网站所展示销售的产品仅供科研!

             沪ICP备08023583号-6     
    产品咨询
    QQ扫码沟通
    在线客服
    服务电话
    400-968-7988
    扫码关注
    微信公众号二维码

    沪公网安备 31011202007338号

    网站地图